1 terminated, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Organ Failure, Multiple: new trials by email Literature Review of Organ Failure, Multiple trials Research Report on Organ Failure, Multiple
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery rejuvesol Solution, Standard Care - Organ Failure, Multiple, Inflammation | Phase 2 | Withdrawn | University of Leicester | 2020-12-01 | 2021-04-29 | |
| The Val-CARD Trial Sodium Valproate - Cardiac Valve Disease, Coronary Artery Disease | Phase 1 / Phase 2 | Terminated | University of Leicester | 45 | 2018-11-06 | 2026-08-17 |
Multiple Organ Failure (2) · Coronary Artery Disease (1) · Heart Valve Diseases (1) · Inflammation (1) · Sepsis (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Shock (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Infections (1) · Myocardial Ischemia (1) · Systemic Inflammatory Response Syndrome (1) · Vascular Diseases (1)
Standard of Care (1) · Valproic Acid (1)
United Kingdom (2)
Gavin J Murphy, Prof (1) · Gavin Murphy, MD (1) · Marius Roman, MD (1)
2018 (1)